Австралія - англійська - APVMA (Australian Pesticides and Veterinary Medicines Authority)

elanco australasia pty ltd - benazepril hydrochloride - oral tablet - benazepril hydrochloride ungrouped active 2.5 mg/tb - cardiovascular system - cat | dog | bitch | castrate | cat - queen | cat - tom | kitten | puppy - chronic kidney disease | chronic renal insufficiency | congestive heart failure | hypertrophic cardiomyopathy | dilated cardiomyopathy | mitral and/or tricuspid regur | valvular insufficiency

Нова Зеландія - англійська - Medsafe (Medicines Safety Authority)

glaxosmithkline nz limited - amoxicillin trihydrate 57.394 mg/ml equivalent to amoxycillin 50mg/ml;  ; potassium clavulanate 14.89 mg/ml equivalent to clavulanic acid 12.5mg/ml - powder for oral suspension - 250 mg/5ml - active: amoxicillin trihydrate 57.394 mg/ml equivalent to amoxycillin 50mg/ml   potassium clavulanate 14.89 mg/ml equivalent to clavulanic acid 12.5mg/ml excipient: aspartame colloidal silicon dioxide golden syrup flavour 52927 ap0551 hydrated silica hypromellose orange flavour phs-134215 orange flavour sd653970 raspberry flavour nn07943 succinic acid xanthan gum - augmentin should be used in accordance with local official antibiotic prescribing guidelines and local susceptibility data. augmentin is indicated for the short term treatment of common bacterial infections in adults and children such as: upper respiratory tract infections (including ent): e.g. tonsillitis, sinusitis, otitis media lower respiratory tract infections: e.g. acute exacerbations of chronic bronchitis, lobar and broncho pneumonia genito-urinary tract infections: e.g. cystitis, urethritis, pyelonephritis, female genital infections skin and soft tissue infections bone and joint infections: e.g. osteomyelitis other infections: e.g. septic abortion, puerperal sepsis, intra-abdominal sepsis, septicaemia, peritonitis, post-surgical infections susceptibility to augmentin will vary with geography and time. local susceptibility data should be consulted where available, and microbiological sampling and susceptibility testing performed where necessary. infections caused by amoxicillin susceptible organisms are amenable to augmentin treatment due to its amoxicillin content. mixed infections caused by amoxicillin susceptible organism in conjunction with augmentin susceptible beta-lactamase-producing organisms may therefore be treated by augmentin.

Нова Зеландія - англійська - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - enoxaparin sodium 150 mg/ml;   - solution for injection - 150 mg/ml - active: enoxaparin sodium 150 mg/ml   excipient: water for injection - - treatment of venous thromboembolic disease. - prevention of thrombus formation in the extra-corporeal circulation during haemodialysis.

Нова Зеландія - англійська - Medsafe (Medicines Safety Authority)

inova pharmaceuticals (new zealand) limited - pholcodine 3 mg/ml;  ;  ;  ; pholcodine 3 mg/ml - oral solution - 3 mg/ml - active: pholcodine 3 mg/ml       excipient: apricot flavour 012500 citric acid hyetellose methyl hydroxybenzoate purified water saccharin sodium sorbitol sunset yellow fcf active: pholcodine 3 mg/ml excipient: apricot flavour 012500 citric acid disodium edetate hyetellose purified water saccharin sodium sodium benzoate sodium citrate sorbitol sunset yellow fcf

Нова Зеландія - англійська - Medsafe (Medicines Safety Authority)

alcon laboratories (new zealand) limited - naphazoline hydrochloride 0.1% (0.105% with manufacturers overage.) - eye drops, solution - 0.1 % - active: naphazoline hydrochloride 0.1% (0.105% with manufacturers overage.) excipient: benzalkonium chloride boric acid disodium edetate dihydrate hydrochloric acid potassium chloride purified water sodium carbonate monohydrate sodium chloride - naphcon forte eye drops are indicated for use as a topical ocular vasoconstrictor.

Нова Зеландія - англійська - Medsafe (Medicines Safety Authority)

abbvie limited - prednisolone acetate 1%{relative};   - eye drops, solution - 1 % - active: prednisolone acetate 1%{relative}   excipient: benzalkonium chloride boric acid hydrochloric acid hypromellose polysorbate 80 purified water sodium chloride sodium citrate dihydrate sodium edetate sodium hydroxide - pred forte® is indicated for the treatment of steroid-responsive inflammation of the palpebral and bulbar conjunctiva, cornea, and anterior segment of the globe.

Нова Зеландія - англійська - Medsafe (Medicines Safety Authority)

sanofi-aventis new zealand limited - alimemazine tartrate 0.6%{relative};  ; alimemazine tartrate 0.6%{relative} - syrup - 30 mg/5ml - active: alimemazine tartrate 0.6%{relative}   excipient: ascorbic acid citric acid as monohydrate ethanol prunus armeniaca purified water sodium benzoate sodium citrate dihydrate sodium metabisulfite sodium sulfite sucrose active: alimemazine tartrate 0.6%{relative} excipient: ascorbic acid citric acid monohydrate ethanol prunus armeniaca purified water sodium benzoate sodium citrate dihydrate sodium metabisulfite sodium sulfite sucrose - · urticaria

Ірландія - англійська - HPRA (Health Products Regulatory Authority)

sanofi-aventis ireland limited t/a sanofi - enoxaparin sodium - solution for injection in pre-filled syringe - 150 milligram(s)/millilitre - heparin group; enoxaparin

Ірландія - англійська - HPRA (Health Products Regulatory Authority)

amdipharm limited - erythromycin - granules for oral suspension - 500 mg/5ml - macrolides; erythromycin

Мальта - англійська - Medicines Authority

jv healthcare limited navi buidlings, pantar road, lija, lja 2021, malta - mefenamic acid - film-coated tablet - mefenamic acid 500 mg - antiinflammatory and antirheumatic products